Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

Leadership Development Program Policy & Advocacy Overview ASCO Advocacy: How to Get Involved Ryan Strandlund Grassroots Advocacy Specialist SCOS/NCOA 2024 Joint Conference February 16, 2024 Why Advocate? • You are the experts • Ensure policies prioritize patient well-being and improved outcomes • Your insights and real-world examples are vital to ensuring lawmakers …
PowerPoint Presentation Evolving Treatment Paradigms for HR+ Breast Cancer: Key Updates from SABCS 2023 SCOS/NCOA Joint Conference 2024 Charlotte, South Carolina Seth A. Wander, MD, PhD Assistant Professor of Medicine Harvard Medical School Massachusetts General Hospital swander@mgh.harvard.edu Disclosures • Consulting/Advisory Board: Foundation Medicine, Veracyte, …
PowerPoint Presentation 2024 Final Medicare Payment Rules Gina Hoxie Director, Payment & Access SCOS/NCOA 2024 Joint Conference February 16, 2024 Agenda 1. Conversion Factor 2. Specialty Impact 3. Evaluation and Management 4. New Codes to Address Health Equity 5. Telehealth 6. Dental Coverage 7. Other Policy Updates 8. Quality Payment Program 9. Outpatient Prospective Payment …
PowerPoint Presentation 2024 Final Medicare Payment Rules Gina Hoxie Director, Payment & Access SCOS/NCOA 2024 Joint Conference February 16, 2024 Agenda 1. Conversion Factor 2. Specialty Impact 3. Evaluation and Management 4. New Codes to Address Health Equity 5. Telehealth 6. Dental Coverage 7. Other Policy Updates 8. Quality Payment Program 9. Outpatient Prospective Payment …
PowerPoint Presentation Adoptive Cell Therapies in Solid Tumors Stacey L. Doran, MD Assistant Research Physician Center for Immuno-Oncology (CIO) Center for Cancer Research, NIH Disclosures • No personal disclosures • CME Consideration: There are (currently) no FDA-approved cellular therapies for solid tumors. Presented early-phase and ongoing clinical trials will …
PowerPoint Presentation Evolving Treatment Paradigms for HR+ Breast Cancer: Key Updates from SABCS 2023 SCOS/NCOA Joint Conference 2024 Charlotte, South Carolina Seth A. Wander, MD, PhD Assistant Professor of Medicine Harvard Medical School Massachusetts General Hospital swander@mgh.harvard.edu Disclosures • Consulting/Advisory Board: Foundation Medicine, Veracyte, …
February 22, 2024
You're invited to participate in Targeted Oncology's Community You’re invited to participate in the Targeted Oncology™ Community Case Forum™ on Wednesday, February 21 at Hilton Phoenix Tapatio Cliffs Resort in Phoenix, Arizona. Healthcare Research & Analytics offers compensation of $750 to medical oncologists/hematologists for their consultative insights. With prior approval from our registration …
PowerPoint Presentation Head and Neck Multidisciplinary Review Agenda Review current practices for Head and Neck Cancers Locally Advanced Oropharyngeal Cancer Metastatic Oral Cavity Cancer Explore the multidisciplinary care of Head and Neck Patients Medical Oncology Radiation Oncology Oral Medicine Nutritional Services 2 Learning Objectives • Understand …
PowerPoint Presentation Head and Neck: A Panel of Thoughts Daniel R Carr izosa, MD, MS, FACP Associate Professor of Medic ine, Divis ion of Hematology/Oncology – W ake Forest School of Medic ine Atr ium Health W ake Forest Bapt ist Comprehensive Cancer Center – Levine Cancer Inst i tute Char lotte Campus SCOS/NCOA Joint Conference – Charlotte, NC February 17th, 2024 …
Leadership Development Program Policy & Advocacy Overview ASCO Advocacy: How to Get Involved Ryan Strandlund Grassroots Advocacy Specialist SCOS/NCOA 2024 Joint Conference February 16, 2024 Why Advocate? • You are the experts • Ensure policies prioritize patient well-being and improved outcomes • Your insights and real-world examples are vital to ensuring lawmakers …
Demographics of the Emerging Drug Market in the United States The emerging consumer demand for equitable healthcare 1 DEMOGRAPHIC SHIFT Arizona Georgia Florida New Jersey California Nevada New Mexico Texas Hawaii Maryland Louisiana New York Alaska Existing Majority Minority States Will Turn Majority Minority in 2020s Will turn Majority …
PowerPoint Presentation The CRISPR Revolution and the New Era of Genome Editing Kevin Davies PhD Executive Editor, The CRISPR Journal; SCOS/NCOA 2024 Author, Editing Humanity Charlotte NC | 2.17.24 “We think we have the found the basic copying mechanism by which life came from life… Read this carefully so that you understand it. When …
ASSOCIATION OF CANCER CARE CENTERS Multidisciplinary Approaches to Addressing the Needs of Patients with Gynecologic Cancers: A Call-to-Action Summit Gynecologic cancer refers to any malignancy that begins in the reproductive organs.1 There are 5 main types of gyne-cologic cancer including cervical, ovarian, uterine, vaginal, and vulvar. Gynecologic malignancies, while less common …
Recent advancements in treatment and a multimodal approach to care are improving outcomes for patients with head and neck cancer, however access to therapies and unique patient challenges due to disease symptoms, difficulty eating, difficulty communicating, and other psychosocial factors can reduce patient quality of life.
February 20, 2024
5:30 PM – 8:30 PM HST Honolulu, HI Join us on the evening of February 20th in at The Bentley Room in Honolulu for a comprehensive review of scientific updates in clinical and translation hematologic research presented at the 2023 ASH Annual Meeting this past December. Hear key highlights from some of the most impactful data presented at this premier event and learn how it can help improve your patient …
February 17, 2024
You’re invited to participate in the Targeted Oncology™ and Oncology Nursing News® Community Case Forum™ on Friday, February 16 at JW Marriott Charlotte in Charlotte, North Carolina. Healthcare Research & Analytics offers compensation of $750 to medical oncologists/hematologists and $500 to advanced practice providers for their consultative insights. After arriving, you’ll spend some time networking …
Spring 2024 Tri-State Save the Date
February 16, 2024
Topic: How to Fulfill the Potential of Antibody-Drug Conjugates as the Next Frontier in Precision Lung Cancer Care You are invited to join us in-person on for the Amplifying the ADC Advantage Symposium, hosted by the Tennessee Oncology Practice Society (TOPS) and PeerView Live. Gain insights from expert, Melissa L. Johnson, MD, as she delves into unlocking the potential of Antibody-drug …
February 16, 2024
Friday, February 16: 12 PM - 5 PM, Reception: 5 PM - 6 PM Saturday, February 17: 8 AM - 3 PM Dramatic changes in healthcare reform are requiring oncology practices to think outside the box in order to maximize operations and contain costs. Join us for the annual 2024 South Carolina Oncology Society/ North Carolina Oncology Association Joint Conference to experience collaborative opportunities that …
NCOA ONCOLOGY DRUG NEWSLETTER F E B R U A R Y 2 0 2 4 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Enfortumab Vedotin-Ejfv (Padcev) and Pembrolizum- ab (Keytruda) The FDA has granted approval to the combination of enfortumab vedotin-ejfv (Padcev) and pembrolizumab …